$MRNA might’ve cured skin cancer essentially.
This $25B company just soared 100% in pre-market because Moderna, Merck cancer vaccine shows promise in late-stage trial.
The vaccine is based on MRNA technology, the same which was used on a large scale, for the first time, in the
